Ezetimibe/rosuvastatin
Ezetimibe/rosuvastatin, sold under the brand name Ridutrin among others, is a cholesterol lowering combination drug.[3] In some countries it is sold as a kit or a pack containing two distinct pills.[4][1]
| Combination of | |
|---|---|
| Ezetimibe | Hypolipidemic agent |
| Rosuvastatin | Statin |
| Clinical data | |
| Trade names | Ridutrin, Lipocomb, Rosuzet, others[1][2] |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| KEGG | |
References
- "Rosuvastatin international". Drugs.com. 3 February 2020. Retrieved 17 February 2020.
- "Ezetimibe / rosuvastatin: List of nationally authorised medicinal products" (PDF). European Medicines Agency (EMA). 21 March 2018. PSUSA/00010271/201707. Retrieved 17 February 2020.
- "Ridutrin SmPC" (PDF). Medicines Data Bank. 30 May 2019. Retrieved 17 February 2020.
- "Rosuzet Composite Pack". NPS MedicineWise. 8 January 2020. Retrieved 17 February 2020.
External links
- "Ridutrin (rosuvastatin zinc/ezetimibe) Public Assessment Report Scientific discussion" (PDF). NL/H/3017/001-003/DC.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.